Phosphatidylserine targeting fusion molecules and methods for their use
US11352404B2 · kind B2 · utility
0Cited by
5References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2018 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Jul 24, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Fusion molecules of a cytokine or portion thereof and a polypeptide which targets the fusion protein to phosphatidylserine, pharmaceutical compositions thereof, and methods for their use in targeting a cytokine or portion thereof to a pathological site and treating a disease or condition responsive to cytokine treatment are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.